AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
2.060
+0.030 (1.48%)
At close: May 12, 2025, 4:00 PM
2.060
0.00 (-0.01%)
After-hours: May 12, 2025, 7:57 PM EDT
AbCellera Biologics Employees
AbCellera Biologics had 596 employees as of December 31, 2024. The number of employees increased by 10 or 1.71% compared to the previous year.
Employees
596
Change (1Y)
10
Growth (1Y)
1.71%
Revenue / Employee
$38,782
Profits / Employee
-$281,658
Market Cap
613.85M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ABCL News
- 9 hours ago - AbCellera's Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit - Business Wire
- 3 days ago - AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting - Business Wire
- 4 days ago - AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - AbCellera Reports Q1 2025 Business Results - Business Wire
- 13 days ago - AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025 - Business Wire
- 4 weeks ago - AbCellera to Participate at Upcoming Investor Conferences in May and June - Business Wire
- 5 weeks ago - AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025 - Business Wire
- 6 weeks ago - AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025 - Business Wire